Anjali Ganguli

Corporate Officer/Principal at SYNDAX PHARMACEUTICALS, INC.

48 year

Health Technology

Consumer Services

Profile

Anjali Ganguli is currently the Chief Business Officer at Syndax Pharmaceuticals, Inc. She previously worked as the VP-Corporate Development at Regado Biosciences, Inc. from 2014 to 2015.
Dr. Ganguli completed her undergraduate degree at The University of Chicago and holds a doctorate from the University of Michigan.

Anjali Ganguli active positions

Companies	Position	Start
SYNDAX PHARMACEUTICALS, INC.	Corporate Officer/Principal	2015-04-30

All active positions of Anjali Ganguli

Former positions of Anjali Ganguli

Companies	Position	End
Regado Biosciences, Inc. Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.	Corporate Officer/Principal	2015-04-30

See the detail of Anjali Ganguli's experience

Training of Anjali Ganguli

The University of Chicago	Undergraduate Degree
University of Michigan	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anjali Ganguli's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SYNDAX PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Regado Biosciences, Inc. Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.	Health Technology